Silence Therapeutics Plc - American Depository Share revenue breakdown overview

Silence Therapeutics Plc - American Depository Share revenue for the last year amounted to 42.86 M USD, the most of which — 43.26 M USD — came from its highest performing source at the moment, Ribonucleic Acid Therapeutics, the year earlier bringing 31.54 M USD. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought Silence Therapeutics Plc - American Depository Share 43.11 M USD, and the year before that — 30.84 M USD.